Literature DB >> 6436316

Association of infection caused by Pseudomonas aeruginosa serotype O11 with intravenous abuse of pentazocine mixed with tripelennamine.

M H Levin, R A Weinstein, C Nathan, R K Selander, H Ochman, S A Kabins.   

Abstract

From July 1979 to June 1983, 25 of 40 intravenous drug addicts with systemic infections had Pseudomonas aeruginosa as the etiological agent; by 1982, P. aeruginosa had replaced Staphylococcus aureus as the most common pathogen. At least 21 of the 25 addicts with P. aeruginosa infection abused pentazocine mixed with tripelennamine (commonly known as T's and blues) compared with 6 of 15 addicts infected with other pathogens (P = 0.006). Of the 25 P. aeruginosa isolates, 23 were of serotype O11. Phenotypic patterns in isolates from addicts and in 22 serotype O11 control isolates from nonaddicts were determined by pyocin and electrophoretic enzyme typing, as well as by susceptibility to heavy metals and antibiotics. Of 25 isolates from addicts, 20 were identical or differed by only one marker, whereas the 22 nonaddict serotype O11 isolates were distributed among 17 distinct phenotypic patterns. We postulate that the emergence of P. aeruginosa as the major cause of deep infection in addicts is a consequence of contamination of their paraphernalia during preparation of pentazocine and tripelennamine for self-injection. The phenotypic similarity among isolates from addicts may reflect acquisition from related environmental sources and an unusual ability of certain serotype O11 strains to survive preparation of the drugs or to be invasive.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436316      PMCID: PMC271426          DOI: 10.1128/jcm.20.4.758-762.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Isolation of large bacterial plasmids and characterization of the P2 incompatibility group plasmids pMG1 and pMG5.

Authors:  J B Hansen; R H Olsen
Journal:  J Bacteriol       Date:  1978-07       Impact factor: 3.490

2.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

Review 3.  Changing epidemiology and newer aspects of infective endocarditis.

Authors:  C Watanakunakorn
Journal:  Adv Intern Med       Date:  1977

4.  Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse.

Authors:  J Mills; D Drew
Journal:  Ann Intern Med       Date:  1976-01       Impact factor: 25.391

5.  Isolation of inc P-2 plasmid DNA from Pseudomonas aeruginosa.

Authors:  M Fennewald; W Prevatt; R Meyer; J Shapiro
Journal:  Plasmid       Date:  1978-02       Impact factor: 3.466

6.  Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis.

Authors:  D A Portnoy; S L Moseley; S Falkow
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

7.  Medical and psychiatric complications of pentazocine and tripelennamine abuse.

Authors:  H W Lahmeyer; R G Steingold
Journal:  J Clin Psychiatry       Date:  1980-08       Impact factor: 4.384

8.  Further studies in the pyocine typing of Pseudomonas pyocyanea.

Authors:  J R Govan; R R Gillies
Journal:  J Med Microbiol       Date:  1969-02       Impact factor: 2.472

9.  Plasmid-determined resistance to tellurium compounds.

Authors:  A O Summers; G A Jacoby
Journal:  J Bacteriol       Date:  1977-01       Impact factor: 3.490

10.  Genetic diversity and structure in Escherichia coli populations.

Authors:  R K Selander; B R Levin
Journal:  Science       Date:  1980-10-31       Impact factor: 47.728

View more
  12 in total

1.  Multilocus enzyme electrophoresis of major O-antigen reference strains of Pseudomonas aeruginosa.

Authors:  C Charnock; T Bergan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

2.  Genetic diversity in relation to serotype in Escherichia coli.

Authors:  D A Caugant; B R Levin; I Orskov; F Orskov; C Svanborg Eden; R K Selander
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

Review 3.  Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics.

Authors:  R K Selander; D A Caugant; H Ochman; J M Musser; M N Gilmour; T S Whittam
Journal:  Appl Environ Microbiol       Date:  1986-05       Impact factor: 4.792

4.  Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.

Authors:  D P Speert; S W Farmer; M E Campbell; J M Musser; R K Selander; S Kuo
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

5.  Case Report: Injectable pentazocine abuse leading to necrotizing soft tissue infection and florid osteomyelitis.

Authors:  Colin Mudrick; Jonathan Isaacs; Jessica Frankenhoff
Journal:  Hand (N Y)       Date:  2011-09-09

6.  Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa.

Authors:  D P Speert; M E Campbell; S W Farmer; K Volpel; A M Joffe; W Paranchych
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

Review 7.  Epidemiological typing of Pseudomonas aeruginosa.

Authors:  T L Pitt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

8.  Structural studies of malate dehydrogenases (MDHs): MDHs in Brevundimonas species are the first reported MDHs in Proteobacteria which resemble lactate dehydrogenases in primary structure.

Authors:  C Charnock
Journal:  J Bacteriol       Date:  1997-06       Impact factor: 3.490

9.  Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors.

Authors:  J A Lomholt; K Poulsen; M Kilian
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

10.  Complexity of Pseudomonas aeruginosa infection in cystic fibrosis: combined results from esterase electrophoresis and rDNA restriction fragment length polymorphism analysis.

Authors:  E Denamur; B Picard; P Goullet; E Bingen; N Lambert; J Elion
Journal:  Epidemiol Infect       Date:  1991-06       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.